|
|
Joseph T Bass, MD, PhD
Director, Center for Diabetes and Metabolism Chief of Endocrinology in the Department of Medicine Charles F. Kettering Professor of Medicine Professor of Medicine (Endocrinology) and Weinberg College of Arts and Sciences Northwestern Memorial Hospital |
Northwestern Medicine Endocrinology, Metabolism and Molecular Medicine department is dedicated to providing outstanding education, impactful clinical and scientific research and excellent patient care. We are thrilled to share our key activities and accomplishments from 2023, and recognize the people who made them possible.
As the Chief of Endocrinology, Metabolism and Molecular Medicine, I am humbled by the trust that our patients place in us, and inspired by the trainees we teach to be the next generation of Endocrinologists. We are excited to continue our cutting-edge research and make even greater strides in 2024. |
JOSEPH BASS, MD, RECEIVED A 2023 LAUREATE AWARD FROM THE ENDOCRINE SOCIETY, AND A 2023 SLEEP RESEARCH SOCIETY AWARD
Joseph Bass, MD, PhD, discusses his research that earned merit from leading associations.
UNCOVERING THE RISKS OF ESSENTIAL METALS SUPPLEMENTS ON DIABETES
Malek El Muayed, MD discusses the impact of diet and environmental elements on Type 2 diabetes risk, with a focus on metals and metalloids. He covers the link between pre-diabetes and increased diabetes risk, and the potential risks of excess intake of essential metals, such as zinc and selenium.
CHANGING THE CONVERSATION AROUND OBESITY
Robert Kushner, MD discusses the approval of the new obesity management drug, tirzepatide, as a treatment option for patients.
TRANSFORMING PATIENT CARE: NORTHWESTERN MEDICINE'S TRAILBLAZING APPROACH TO CGM IN EPIC
Northwestern Medicine is charting the future with a transformation in how continuous glucose monitoring (CGM) and data integration occurs.
GLP-1 AGONISTS FOR WEIGHT LOSS
Robert Kushner, MD reviews recent findings and potential treatments that weight loss experts are considering for patient care.
EPIDEMICS OF OBESITY AND DIABETES
Lisa R. Beutler, MD, PhD,discusses her research on how the gut and the brain communicate with each other to maintain body weight, and how this goes awry in diseases such as obesity.
EXPERT GUIDANCE ON OFF-LABEL USE OF HCL THERAPY IN PREGNANCIES COMPLICATED BY DIABETES
Emily D. Szmuilowicz, MD and colleagues provide expert guidance on the off-label use of hybrid closed-loop (HCL) therapy in pregnancies complicated by diabetes.
DIABETES AND DISPARITIES IN CONTINOUS GLUCOSE MONITORING IN COMMUNITY HEALTH CARE SETTINGS
Amisha Wallia, MD, MS, explores some of the common challenges faced by individuals with diabetes in accessing and utilizing CGM technology in community healthcare settings.
Joseph Bass, MD, PhD, discusses his research that earned merit from leading associations.
UNCOVERING THE RISKS OF ESSENTIAL METALS SUPPLEMENTS ON DIABETES
Malek El Muayed, MD discusses the impact of diet and environmental elements on Type 2 diabetes risk, with a focus on metals and metalloids. He covers the link between pre-diabetes and increased diabetes risk, and the potential risks of excess intake of essential metals, such as zinc and selenium.
CHANGING THE CONVERSATION AROUND OBESITY
Robert Kushner, MD discusses the approval of the new obesity management drug, tirzepatide, as a treatment option for patients.
TRANSFORMING PATIENT CARE: NORTHWESTERN MEDICINE'S TRAILBLAZING APPROACH TO CGM IN EPIC
Northwestern Medicine is charting the future with a transformation in how continuous glucose monitoring (CGM) and data integration occurs.
GLP-1 AGONISTS FOR WEIGHT LOSS
Robert Kushner, MD reviews recent findings and potential treatments that weight loss experts are considering for patient care.
EPIDEMICS OF OBESITY AND DIABETES
Lisa R. Beutler, MD, PhD,discusses her research on how the gut and the brain communicate with each other to maintain body weight, and how this goes awry in diseases such as obesity.
EXPERT GUIDANCE ON OFF-LABEL USE OF HCL THERAPY IN PREGNANCIES COMPLICATED BY DIABETES
Emily D. Szmuilowicz, MD and colleagues provide expert guidance on the off-label use of hybrid closed-loop (HCL) therapy in pregnancies complicated by diabetes.
DIABETES AND DISPARITIES IN CONTINOUS GLUCOSE MONITORING IN COMMUNITY HEALTH CARE SETTINGS
Amisha Wallia, MD, MS, explores some of the common challenges faced by individuals with diabetes in accessing and utilizing CGM technology in community healthcare settings.